ADAR1 Capital Management, LLC 13D and 13G filings for Acasti Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 7:44 pm Purchase | 2025-09-30 | 13G | Acasti Pharma Inc. ACST | ADAR1 Capital Management, LLC | 1,534,254 9.900% | 32,111 (+2.14%) | Filing |
| 2025-05-15 7:33 pm Purchase | 2025-03-31 | 13G | Acasti Pharma Inc. ACST | ADAR1 Capital Management, LLC | 1,502,143 9.990% | 472,146 (+45.84%) | Filing |
| 2024-11-14 4:40 pm Purchase | 2024-09-30 | 13G | Acasti Pharma Inc. ACST | ADAR1 Capital Management, LLC | 1,029,997 9.990% | 70,426 (+7.34%) | Filing |
| 2024-07-10 9:10 pm Purchase | 2024-06-28 | 13G | Acasti Pharma Inc. ACST | ADAR1 Capital Management, LLC | 959,571 10.200% | 959,571 (New Position) | Filing |